Inhibrx Biosciences, Inc. (INBX NASDAQ) stock market data APIs
$128.8067
0.57(0.4%)
as of May 5, 2026
Try our APIs with
free plan!
Inhibrx Biosciences, Inc. Financial Data Overview
Price chart is built with
Anychart
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Prev. Close
128.8067
Open
129.3743
High
133.3872
Low
126.4243
52 wk Range
10.84-155.29
Market Cap
1 871 M
Shares Outstanding
14 607 K
Revenue
1 300 K
EPS
-2.11
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Inhibrx Biosciences, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Inhibrx Biosciences, Inc. data using free add-ons & libraries
Get Inhibrx Biosciences, Inc. Fundamental Data
Inhibrx Biosciences, Inc. Fundamental data includes:
- Net Revenue: 1 300 K
- EBITDA: -132 542 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Inhibrx Biosciences, Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-23
- EPS/Forecast: -1.63
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Inhibrx Biosciences, Inc. News
New
INBX Stock Up on Upbeat Clinical Update From Colorectal Cancer Study
Shares of Inhibrx Biosciences INBX rallied 36.9% on Wednesday. The massive surge was triggered by encouraging updated interim data from INBX’s phase I/II study evaluating ozekibart (INBRX-109) in co...
T-Mobile reportedly in merger talks, Adobe's $25B stock buyback
Market Catalysts Host Julie Hyman tracks several of the day's top trending stock tickers, including AT&T's (T) wireless subscriber growth, Bloomberg reporting T-Mobile (TMUS) is in talks to merge with...
Inhibrx gains as Stifel issues new Buy based on lead assets
[Wall Street New York stock exchange stock market] alexsl Inhibrx Biosciences (INBX [https://seekingalpha.com/symbol/INBX]) traded higher on Wednesday after Stifel launched its coverage of the cancer...
Coinbase downgraded, Deere upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
Get Inhibrx Biosciences, Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
